Start time: 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
The integration of artificial intelligence (AI) with medical imaging in oncology clinical trials has brought about a profound transformation. Its advancements have revolutionized diagnostic accuracy and prognostic insights with advanced image segmentation methods enabling precise delineation of pathological areas and enhancing treatment response measurements. Furthermore, AI’s predictive capabilities offer new avenues for anticipating disease progression and improving therapeutic strategies, all while ensuring patient privacy. Overall, the adoption of AI in oncology clinical trials promises a journey of innovation, encompassing precision diagnostics, predictive modeling, and therapy evolution. This journey navigates complex aspects like patient privacy, data integrity, and stakeholder engagement.
In this discussion, we will delve into the current advancements of AI that are enhancing the efficiency of oncology clinical trials with a focus on medical imaging. Additionally, we will explore the exciting potential that deep learning and generative AI hold in this dynamic field.
Join esteemed speakers, Kim Nguyen, Joël Schaerer, and Alex Boudreau, to explore how AI is transforming medical imaging for oncology-focused clinical trials.
What you’ll learn:
Director, Tech Product Development, Research & Development, Imaging at Clario
Joël Schaerer earned his Ph.D. in 2008, specializing in cardiac imaging. After completing a post-doc on motion management for radiation therapy, he joined Clario in 2011. At Clario, he’s been working on image processing software for various medical applications. In 2017, Joël introduced deep learning to the company’s projects and currently leads Clario’s medical image processing group from his base in Switzerland.
Director, AI, Research & Development, Imaging at Clario
Alex Boudreau is a distinguished leader in the field of artificial intelligence with an academic foundation in physics, cognitive sciences, and computer science. With over two decades of remarkable experience, he has consistently spearheaded the development of cutting-edge software systems and algorithms. His expertise spans a wide spectrum, from pioneering advancements in medical image analysis software to leading the development of enterprise speech systems, conversational AI, and cloud-based fraud detection. Alex Boudreau’s contributions further extend to the realm of intelligent vehicles through the development of state-of-the-art embedded deep learning and generative AI based solutions. Notably, he has also founded a venture-backed software company that provided machine learning powered image analysis solutions for the biomedical industry.
Director, Data Science, Data Science and Delivery at Clario
Kim has 15 years of healthcare experience, supported by his Data Science Master’s from UC San Diego. His academic journey included groundbreaking Alzheimer’s imaging research using electron microscopy, collaborating with a dedicated team during his graduate program.
In his current role as Director of Data Science at Clario, Kim is at the forefront of utilizing the latest machine learning techniques. His mission is to create advanced predictive models, harnessing the power of data to provide innovative solutions that drive results for Clario.
In the webinar, the presenters will discuss the accessibility features and present results to date on this industry first study and provide an insight into the next steps for accessibility functionalities.
December 4, 2023
This webinar explores a comprehensive approach to enhance safety and tolerability assessments in oncology research and will expand your knowledge and contribution to the advancement of patient safety and data quality.
December 13, 2023